Showing 1 - 5 results of 5 for search 'Axel Semjonow', query time: 0.04s Refine Results
  1. 1
    Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate.

    Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate. by Martin Boegemann, Katrin Schlack, Ann-Kathrin Fischer, Joachim Gerß, Julie Steinestel, Axel Semjonow, Andres Jan Schrader, Laura-Maria Krabbe

    Published 2016-01-01
    Get full text
    Article
  2. 2
    The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour’s TMPRSS2-ERG Fusion Status

    The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour’s TMPRSS2-ERG Fusion Status by Dianne van Strijp, Christiane de Witz, Birthe Heitkötter, Sebastian Huss, Martin Bögemann, George S. Baillie, Miles D. Houslay, Chris Bangma, Axel Semjonow, Ralf Hoffmann

    Published 2019-01-01
    Get full text
    Article
  3. 3
    Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology

    Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology by Okyaz Eminaga, Mahmoud Abbas, Christian Kunder, Yuri Tolkach, Ryan Han, James D. Brooks, Rosalie Nolley, Axel Semjonow, Martin Boegemann, Robert West, Jin Long, Richard E. Fan, Olaf Bettendorf

    Published 2024-03-01
    Get full text
    Article
  4. 4
    Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial

    Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial by Dorothee Tiedje, Matthias Borowski, Alexandra Simbrich, Kathrin Schlößler, Klaus Kruse, Christiane Bothe, Katrin Kuss, Charles Christian Adarkwah, Peter Maisel, Ralf Jendyk, Marc-André Kurosinski, Joachim Gerß, Christian Tschuschke, Ralf Becker, Monique J. Roobol, Chris H. Bangma, Hans-Werner Hense, Norbert Donner-Banzhoff, Axel Semjonow

    Published 2021-12-01
    Get full text
    Article
  5. 5
    Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative

    Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative by Sebastiaan Remmers, Jozien Helleman, Daan Nieboer, Bruce Trock, Matthew E. Hyndman, Caroline M. Moore, Vincent Gnanapragasam, Lui Shiong Lee, Oussama Elhage, Laurence Klotz, Peter Carroll, Tom Pickles, Anders Bjartell, Grégoire Robert, Mark Frydenberg, Mikio Sugimoto, Behfar Ehdaie, Todd M. Morgan, Jose Rubio-Briones, Axel Semjonow, Chris H. Bangma, Monique J. Roobol

    Published 2022-07-01
    Get full text
    Article

Search Tools: